University of Dundee

Similar documents
AN INDEPENDENT VALIDATION OF QRISK ON THE THIN DATABASE

RESEARCH. Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study

Supplemental tables/figures

Should we base treatment decisions on short-term or lifetime CVD risk? Rod Jackson University of Auckland New Zealand

Lifetime vs. 10-year risk to allocate treatments for the primary prevention of cardiovascular disease

Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study

Cardiovascular risk factor appraisal art or science?

QStatin Update Information

RESEARCH. Predicting risk of type 2 diabetes in England and Wales: prospective derivation and validation of QDScore

Correlation of novel cardiac marker

Validation of QRISK2 (2014) in patients with diabetes

well-targeted primary prevention of cardiovascular disease: an underused high-value intervention?

Discontinuation and restarting in patients on statin treatment: prospective open cohort study using a primary care database

K D Lawson, 1 E A L Fenwick, 1 A C H Pell, 2 J P Pell 1. Epidemiology

RESEARCH. Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2

Antihypertensive Trial Design ALLHAT

Since 1980, obesity has more than doubled worldwide, and in 2008 over 1.5 billion adults aged 20 years were overweight.

Risk modeling for Breast-Specific outcomes, CVD risk, and overall mortality in Alliance Clinical Trials of Breast Cancer

Key causes of preventable deaths in New Zealand In a population of 10,000 New Zealanders, every year there will be about:

New approaches to the implementation of cardiovascular disease prevention Jørstad, H.T.

COMPETING INTEREST OF FINANCIAL VALUE

Secondary analyses of HSE data and linked health outcomes - an overview of work in progress. UCL (University College London)

Coronary heart disease risk prediction in the Atherosclerosis Risk in Communities (ARIC) study

Family history of premature coronary heart disease and risk prediction in the EPIC-Norfolk prospective population study

QDScore 2011 Annual Update Information

RESEARCH. An independent external validation and evaluation of QRISK cardiovascular risk prediction: a prospective open cohort study

A lthough the hazards of smoking are well described,

EuroPrevent 2010 Fatal versus total events in risk assessment models

Scottish mental health profiles for adults: summary report. Andrew D Millard, Gerry McCartney

Preventing Cardiovascular Disease Stroke Primary Prevention Guidelines. John Potter Professor Ageing & Stroke Medicine University of East Anglia

Diabetes, Diet and SMI: How can we make a difference?

RESEARCH. An independent and external validation of QRISK2 cardiovascular disease risk score: a prospective open cohort study

CVD risk assessment using risk scores in primary and secondary prevention

Lifetime clinical and economic benefits of statin-based LDL lowering in the 20-year Followup of the West of Scotland Coronary Prevention Study

Vascular Diseases. Overview: Selected Slides

Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden

Population base eye screening in Scotland. Challenges of equity and coverage. Graham Leese University of Dundee

Baldness and Coronary Heart Disease Rates in Men from the Framingham Study

Preventing heart disease by controlling hypertension: Impact of hypertensive subtype, stage, age, and sex

What have We Learned in Dyslipidemia Management Since the Publication of the 2013 ACC/AHA Guideline?

Using Cardiovascular Risk to Guide Antihypertensive Treatment Implications For The Pre-elderly and Elderly

CVD Prevention, Who to Consider

Cardiovascular Risk Assessment and Management Making a Difference

1210 factors. However, it refers to the fact that CVD, in most people, is the product of several risk AUROC ⴝ area under the factors that may interact

SPARRA Mental Disorder: Scottish Patients at Risk of Readmission and Admission (to psychiatric hospitals or units)

Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study

Kjersti Stormark Rabanal, 1 Haakon Eduard Meyer, 1,2 Romana Pylypchuk, 3 Suneela Mehta, 3 Randi Marie Selmer, 1 Rodney T Jackson 3.

Epidemiologic Measure of Association

Effectiveness of statins in chronic kidney disease

Development and validation of QDiabetes-2018 risk prediction algorithm to estimate future risk of type 2 diabetes: cohort study

Modelling Reduction of Coronary Heart Disease Risk among people with Diabetes

Screening for Cardiovascular Risk in Asymptomatic Patients

Scottish Diabetes Survey

ORIGINAL ARTICLE. Epidemiology

Europe PMC Funders Group Author Manuscript Heart. Author manuscript; available in PMC 2016 May 17.

Creating a Tobacco-Free Scotland: Addressing the Inequalities Challenge

Coronary heart disease statistics edition. Steven Allender, Viv Peto, Peter Scarborough, Anna Boxer and Mike Rayner

Combined effects of systolic blood pressure and serum cholesterol on cardiovascular mortality in young (<55 years) men and women

The polypill in the primary prevention of cardiovascular disease

Assessing the economics of a stratified treatment approach for Type 2 Diabetes

. Time to transplant listing is dependent on. . In 2003, 9.1% of all prevalent transplant. . Patients with diabetes mellitus are less

Individual Participant Data (IPD) Meta-analysis of prediction modelling studies

Developing and validating a cardiovascular risk score for patients in the community with prior

Lung cancer: the importance of seeing a respiratory physician

Depok-Indonesia STEPS Survey 2003

etable 3.1: DIABETES Name Objective/Purpose

Diabetes MAYER B. DAVIDSON, MD,* CO-EDITOR-IN-CHIEF; HENRY N. GINSBERG, MD, REVIEWER; TERRENCE F. FAGAN, MANAGING EDITOR; CHING-LING CHEN, PhD, WRITER

The effect of blood pressure and cholesterol variability on the precision of Framingham cardiovascular risk estimation: a simulation study

Appendix S1. List of Figures. List of Tables

The value of stratified economic analysis in cohort-level models: A case study on interventions for obstructive sleep apnea

Online Appendix (JACC )

Ambulatory arterial stiffness index as a predictor of cardiovascular events.

CVD Risk Assessment. Michal Vrablík Charles University, Prague Czech Republic

High-sensitivity Troponin T Predicts Recurrent Cardiovascular Events in Patients with Stable Coronary Heart Disease: KAROLA Study 8 Year FU

Why Do We Treat Obesity? Epidemiology

Economically efficient approaches to address chronic disease in developing countries

A REPORT PREPARED FOR THE UK NATIONAL SCREENING COMMITTEE

Identification of subjects at high risk for cardiovascular disease

The management of diabetes

European Journal of Cardiovascular Prevention & Rehabilitation

ESM1 for Glucose, blood pressure and cholesterol levels and their relationships to clinical outcomes in type 2 diabetes: a retrospective cohort study

NICE Indicator Programme. Consultation on proposed amendments to current QOF indicators

Heart Age and Cardiovascular Risk

Sarah J. E. Barry 1 *, Eleanor Dinnett 2, Sharon Kean 1, Allan Gaw 3, Ian Ford 1. Abstract. Introduction

Deposited on: 2 June 2010

Diabetes Mellitus: A Cardiovascular Disease

Supplementary Online Content

HEALTH TARGETS IN PRIMARY CARE

How do we protect from the harms of second-hand smoke [SHS]?

Central pressures and prediction of cardiovascular events in erectile dysfunction patients

Tackling cancer inequalities in Scotland

Setting The setting was primary care. The economic study was carried out in the UK.

CONTENT SUPPLEMENTARY FIGURE E. INSTRUMENTAL VARIABLE ANALYSIS USING DESEASONALISED PLASMA 25-HYDROXYVITAMIN D. 7

Supplementary Online Content

Wine, Alcohol, and Cardiovascular Health: Revisiting the Health Benefits of Wine in the Framingham Heart Study. Michael Darden and Douglas Nelson

Outcomes and Perspectives of Single-Pill Combination Therapy for the modern management of hypertension

Supplement materials:

Type of intervention Primary prevention; secondary prevention. Economic study type Cost-effectiveness analysis and cost utility analysis.

Transcription:

University of Dundee Cardiovascular Epidemiology Unit Why Scotland is adding Social Deprivation and Family History to cardiovascular risk assessment in the ASSIGN score H. Tunstall-Pedoe

University of Dundee Cardiovascular Epidemiology Unit on behalf of SIGN working group on risk estimation

SOCIAL DEPRIVATION = SIMD (Scottish Index of Social Deprivation) Postcodes 208,609 Range of SIMD for postcodes = 0.94 to 89.09 Mean 21.21, STD 16.32, Median 16.28.

SIMD LOOK-UP TABLE AB1 0NA 9.06 AB1 0NB 9.37 AB1 0ND 9.37 AB1 0NE 4.36 AB1 0NJ 6.65 AB1 0NL 6.65 AB1 0NN 9.84 AB1 0NP 6.65 AB1 0NQ 4.36 Etcetera 208, 600 more!!!

Millionaires row Hermitage Drive, Edinburgh, EH10 6BZ SIMD = 1.14

Social deprivation row Torr St, Possil, Glasgow G22 5EE SIMD = 87.61

ASSIGN ASSessing cardiovascular risk using SIGN guidelines to ASSIGN preventive treatment SIGN= Scottish Intercollegiate Guidelines Network

Further information Website assign-score.com Publications Heart 2006; 92: 307-10 Heart 2007; 93: 172-6

Purpose First premiss The purpose of cardiovascular risk scores is not primarily the prediction of individual risk. Second premiss It is to prioritize giving preventive treatment to those at greatest risk. Third premiss Scores are inherently discriminatory but need to discriminate fairly.

Purpose Fourth premiss This means that everyone above the chosen cut-point for preventive treatment should be at higher risk than everyone below it. Fifth premiss Social and ethnic variation in cardiovascular risk is inadequately explained by classic cardiovascular risk factors

Purpose Sixth premiss If cardiovascular risk scoring is to be applied to whole populations it may need to take account of social and ethnic heterogeneity within those populations.

Questions Question one Is the Framingham cardiovascular score fair (or equitable) when used across a socially heterogeneous population? Question two Can we devise a more socially equitable cardiovascular risk score which performs better than Framingham?

Methods Scottish Heart Health Extended Cohort (SHECC):random population samples recruited 1984-95 Identification of Scottish Index of Multiple Deprivation (SIMD) from postcode (=Zipcode) of address at recruitment.

Methods Follow-up of mortality and morbidity through national registries and record linkage. Cardiovascular mortality and hospital diagnoses of CHD, CBVD, and TIA to end of 2005 (= 10-20 years follow-up)

Methods Calculation of observed rates by fifths of SIMD score. Expected rates calculated from Framingham cardiovascular score. Compare them to assess performance of Framingingham score with respect to social equity.

Question one results 6540 men, 1604 developed CVD, 743 within 10 years 6757 women, 1015 developed CVD, 422 within 10 years

CVD 10y risk percent Framingham O & E Men O RR E RR O/E RR 1 7.5 1.0 13.5 1.0 0.6 1.00 2 10.7 1.4 15.5 1.1 0.7 1.26 3 11.5 1.6 15.4 1.1 0.8 1.35 4 11.5 1.6 17.0 1.3 0.7 1.23 5 13.8 1.9 17.5 1.3 0.8 1.43 Women 1 2.0 1.0 6.7 1.0 0.3 1.00 2 3.3 1.6 8.3 1.2 0.4 1.32 3 5.2 2.6 9.2 1.4 0.6 1.87 4 7.5 3.7 10.0 1.5 0.8 2.45 5 9.6 4.7 11.9 1.8 0.8 2.66

Results Question One Compared with the population mean, use of the standard Framingham score results in undertreatment of the socially deprived and overtreatment of the socially advantaged. It is therefore unfair. The effect is relatively greater in women than men, the former having a greater social gradient (relatively) in disease.

Methods Question Two Use the same database to derive a risk score incorporating deprivation with the classic risk factors and any others that prove significant when tested. Compare performance of the new ASSIGN score with the Framingham cardiovascular score within the SHHEC cohort.

Methods Question 2 Cox proportional hazards model Test for linearity of risk factors Kaplan-Meier estimate of survival Observed versus expected, rank correlation, Kappa statistics, discrimination, area under ROC curve, HOTH graph

Results Question Two SIMD score was significant + Family history was significant + Cigarette dosage was significant + Left ventricular hypertrophy not so Body mass index not so

Results: Calibration Incidence (observed) = 11.7% (MEN) Framingham mean = 16.0% ASSIGN mean = 14.4% Framingham median = 13.6% ASSIGN median = 11.7%

Results: Calibration Incidence (observed) = 6.4% (WOMEN) Framingham mean = 9.6% ASSIGN mean = 9.3% Framingham median = 7.1% ASSIGN median = 6.2%

Results: comparison Rank correlation 0.92 in men, 0.90 in women Kappa statistics: at 20% cutoff 0.75 (0.71-0.79) at 30% cutoff 0.59 (0.51-0.67)

Results: comparison Correct allocation in SHHEC cohort ASSIGN 83% at 20% cutoff Framingham 79%. ASSIGN 96% at 30% cutoff Framingham 89%...

Results: Area under the ROC Men curve 0.727 for ASSIGN 0.716 for Framingham (p= 0.02) Women 0.765 for ASSIGN 0.741 for Framingham (p= 0.0001)

CVD 10y risk percent ASSIGN O & E Men O RR E RR O/E RR 1 7.5 1.0 11.0 1.0 0.7 1.00 2 10.7 1.4 12.3 1.1 0.9 1.29 3 11.5 1.6 13.0 1.2 0.9 1.31 4 11.5 1.6 15.0 1.4 0.8 1.14 5 13.8 1.9 17.8 1.6 0.8 1.15 Women 1 2.0 1.0 5.2 1.0 0.4 1.00 2 3.3 1.6 6.4 1.2 0.5 1.33 3 5.2 2.6 7.5 1.4 0.7 1.78 4 7.5 3.7 9.2 1.8 0.8 2.08 5 9.6 4.7 13.9 2.7 0.7 1.76

Cases treated or not % of whole group at 20% treated overall SIMD Fram +ve -ve ASSN +ve -ve 1 1.5 3.3 1.3 3.5 5 6.0 5.6 7.1 4.5 ALL 4.0 4.8 4.1 4.7

Conclusions Framingham and other current scores ignore that component of social and ethnic risk which is not mediated by the classic risk factors. Through a deprivation score and family history ASSIGN addresses deprivation directly and ethnicity indirectly.

Conclusions ASSIGN and Framingham perform quite similarly in tests of discrimination: adding new powerful risk factors adds little to overall discrimination. ASSIGN is not therefore much better overall, but it is more equitable between social groups and is being adopted in Scotland for that reason.

Conclusions ASSIGN was designed for a Scottish population but could be calibrated for others which have an index of social deprivation. Others are copying us (cf QRISK recent BMJ) but we were the first to include a measure of social deprivation.

Workload :% of SHHEC popn above 20% 10y risk SIMD Fram ASSN 40-44 50-54 60-64 40-44 50-54 60-64 Men All 4.7 36 80 3.6 20 70 1 3.5 27 73 1.8 11 41 5 8.0 43 85 9.5 35 85 Women All 0.4 10 41 0.5 5.8 40 1 0.0 4.5 22 0.0 0.8 14 5 0.6 14 56 1.5 16 74

Further information Website assign-score.com Publications Heart 2006; 92: 307-10 Heart 2007; 93: 172-6

SHHEC ASSIGN Age last birthday: 52 years Sex : enter "M" or "F" m SIMD score 21.21 Family history:"y" or "N" n Diabetes:"Y" or "N" n Current cig. smoker: "Y" or "N" y no/day 20 Systolic blood pressure (SBP): 140 mmhg Total cholesterol 6.5 mmol/l HDL cholesterol 1.2 mmol/l SHHEC ASSIGN score 19 FramCV 27 Authors: Mark Woodw ard and Hugh Tunstall Pedoe,

SHHEC ASSIGN Age last birthday: 52 years Sex : enter "M" or "F" m SIMD score 1.1 Family history:"y" or "N" n Diabetes:"Y" or "N" n Current cig. smoker: "Y" or "N" y no/day 20 Systolic blood pressure (SBP): 140 mmhg Total cholesterol 6.5 mmol/l HDL cholesterol 1.2 mmol/l SHHEC ASSIGN score 17 FramCV 27 Authors: Mark Woodw ard and Hugh Tunstall Pedoe,

SHHEC ASSIGN Age last birthday: 52 years Sex : enter "M" or "F" m SIMD score 85 Family history:"y" or "N" n Diabetes:"Y" or "N" n Current cig. smoker: "Y" or "N" y no/day 20 Systolic blood pressure (SBP): 140 mmhg Total cholesterol 6.5 mmol/l HDL cholesterol 1.2 mmol/l SHHEC ASSIGN score 27 FramCV 27 Authors: Mark Woodw ard and Hugh Tunstall Pedoe,

SHHEC ASSIGN Age last birthday: 58 years Sex : enter "M" or "F" f SIMD score 21.21 Family history:"y" or "N" n Diabetes:"Y" or "N" n Current cig. smoker: "Y" or "N" y no/day 20 Systolic blood pressure (SBP): 140 mmhg Total cholesterol 6.5 mmol/l HDL cholesterol 1.2 mmol/l SHHEC ASSIGN score 19 FramCV 25 Authors: Mark Woodw ard and Hugh Tunstall Pedoe,

SHHEC ASSIGN Age last birthday: 58 years Sex : enter "M" or "F" f SIMD score 1.1 Family history:"y" or "N" n Diabetes:"Y" or "N" n Current cig. smoker: "Y" or "N" y no/day 20 Systolic blood pressure (SBP): 140 mmhg Total cholesterol 6.5 mmol/l HDL cholesterol 1.2 mmol/l SHHEC ASSIGN score 16 FramCV 25 Authors: Mark Woodw ard and Hugh Tunstall Pedoe,

SHHEC ASSIGN Age last birthday: 58 years Sex : enter "M" or "F" f SIMD score 85 Family history:"y" or "N" n Diabetes:"Y" or "N" n Current cig. smoker: "Y" or "N" y no/day 20 Systolic blood pressure (SBP): 140 mmhg Total cholesterol 6.5 mmol/l HDL cholesterol 1.2 mmol/l SHHEC ASSIGN score 31 FramCV 25 Authors: Mark Woodw ard and Hugh Tunstall Pedoe,